{
  "main_header": {
    "sid": 10039854,
    "name": "Mahamaya Lifesc.",
    "stock_name": "Mahamaya Lifesc.",
    "full_name": "Mahamaya Lifesciences Ltd",
    "name_url": "stocks-analysis/mahamaya-lifesc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "142.00",
    "chg": 9,
    "chgp": "6.77%",
    "dir": 1,
    "prev_price": "133.00",
    "mcapval": "332.35 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544611,
    "symbol": "",
    "ind_name": "Pesticides & Agrochemicals",
    "ind_code": 18,
    "indexname": "",
    "isin": "INE0U9D01019",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 56400,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mahamaya-lifesc-10039854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039854",
    "stock_news_url": "https://www.marketsmojo.com/news/mahamaya-lifesciences-10039854"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Submission Of Half Year Results - September 2025",
      "datetime": "02-Dec-2025",
      "details": "Submission of Half Year results - September 2025",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Half Yearly Financial Results - September 2025",
      "datetime": "02-Dec-2025",
      "details": "Submission of Half Yearly Financial Results - September 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results",
      "datetime": "26-Nov-2025",
      "details": "Mahamaya Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/12/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the half year ended 30.09.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News